Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
318 participants
OBSERVATIONAL
2019-04-15
2021-09-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study also evaluates the feasibility of the measure and its interobserver variability.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assesment by Ultrasonography of the Perineal-cephalic Distance
NCT02456753
Comparison of the Non-invasive Approach and Fetal Exome Sequencing in Prenatal Diagnosis When Fetal Ultrasound Signs Are Discovered
NCT05182242
Ultrasonic Measurements of the Clitoris in Fetuses
NCT01011400
Fetal Anatomy by Three-Dimensional Ultrasound
NCT00340002
Perinatal Diagnosis of GIT Anomalies
NCT03514940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Urogenital disorders, such as hypospadias and micro-penis, are associated with a shorter anogenital distance.
Anogenital distance is a good marker of fetal exposure to androgenic substances.
Prenatal anogenital distance ultrasound measure can help the diagnosis in case of doubt about fetal sexual phenotype or in case of urogenital disorder suspicion (hypospadias or micropenis).
Is the anogenital distance easy to make measure? Can this procedure be reproduced? What are the threshold values to determine fetal sex at each term of pregnancy?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sonographic fetal follow up in Brest Hospital
* term\>18 weeks of gestation
Exclusion Criteria
* Minor
* no consent
* ultrasound performed by an operator without ultrasonography graduation
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne-Hélène SALIOU
Role: PRINCIPAL_INVESTIGATOR
CHRU Brest - Morvan hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Brest (Morvan)
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DAG (29BRC18.0067)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.